Publicacións en colaboración con investigadores/as de Addenbrooke's Hospital (33)

2024

  1. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)

    Nature Reviews Endocrinology

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adeno-associated virus 2 infection in children with non-A–E hepatitis

    Nature, Vol. 617, Núm. 7961, pp. 555-563

  3. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

    Neurology, Vol. 100, Núm. 23, pp. E2386-E2397

  4. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    Nature Reviews Endocrinology, Vol. 19, Núm. 12, pp. 722-740

  5. Genomic investigations of unexplained acute hepatitis in children

    Nature, Vol. 617, Núm. 7961, pp. 564-573

2022

  1. A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis

    British Journal of Cancer, Vol. 126, Núm. 7, pp. 1082-1090

  2. An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort

    Neurology, Vol. 99, Núm. 12, pp. E1299-E1313

  3. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)

    Nature Communications

  4. Emergence of methicillin resistance predates the clinical use of antibiotics

    Nature, Vol. 602, Núm. 7895, pp. 135-141

  5. Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score

    Neurology, Vol. 98, Núm. 5, pp. E518-E532

2021

  1. Effectiveness of third-class biologic treatment in crohn’s disease: A multi-center retrospective cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

    World Journal of Urology, Vol. 39, Núm. 11, pp. 4247-4253

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  2. Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 733-742

  3. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

    Nature Communications, Vol. 11, Núm. 1

2019

  1. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

    World Journal of Emergency Surgery, Vol. 14, Núm. 1

  2. Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype

    Cancer Cell, Vol. 35, Núm. 2, pp. 256-266.e5

2017

  1. First clinical evaluation of a new single-use flexible ureteroscope (LithoVue™): a European prospective multicentric feasibility study

    World Journal of Urology, Vol. 35, Núm. 5, pp. 809-818

  2. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Nature Genetics, Vol. 49, Núm. 5, pp. 680-691